{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:43:09Z","timestamp":1760150589932,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:00:00Z","timestamp":1702771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Veno-arterial extracorporeal membrane oxygenation (va-ECMO) can provide circulatory and respiratory support in patients with cardiogenic shock. The main aim of this work was to investigate the association of blood biomarkers with mortality in patients with myocardial infarction needing va-ECMO support. Methods: We retrospectively analyzed electronic medical charts from patients receiving va-ECMO support in the period from 2008 to 2021 at the Medical University Innsbruck, Department of Anesthesiology and Intensive Care Medicine. Results: Of 188 patients, 57% (108\/188) survived to discharge, with hemorrhage (46%) and thrombosis (27%) as the most frequent adverse events. Procalcitonin levels were markedly higher in non-survivors compared with survivors during the observation period. The multivariable model identified higher blood levels of procalcitonin (HR 1.01, p = 0.002) as a laboratory parameter associated with a higher risk of mortality. Conclusions: In our study population of patients with myocardial infarction-associated cardiogenic shock, deceased patients had increased levels of inflammatory blood biomarkers throughout the whole study period. Increased procalcitonin levels have been associated with a higher risk of mortality. Future studies are needed to show the role of procalcitonin in patients receiving ECMO support.<\/jats:p>","DOI":"10.3390\/diagnostics13243683","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T08:55:29Z","timestamp":1702889729000},"page":"3683","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ECMO in Myocardial Infarction-Associated Cardiogenic Shock: Blood Biomarkers as Predictors of Mortality"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-244X","authenticated-orcid":false,"given":"Thomas","family":"Senoner","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-7338","authenticated-orcid":false,"given":"Benedikt","family":"Treml","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Breitkopf","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulvi Cenk","family":"Oezpeker","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3950-7262","authenticated-orcid":false,"given":"Nicole","family":"Innerhofer","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-661X","authenticated-orcid":false,"given":"Christine","family":"Eckhardt","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra Radovanovic","family":"Spurnic","sequence":"additional","affiliation":[{"name":"Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-3662","authenticated-orcid":false,"given":"Sasa","family":"Rajsic","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,17]]},"reference":[{"key":"ref_1","unstructured":"Brogan, T.V., Lequier, L., Lorusso, R., MacLaren, G., and Peek, G.J. (2017). Extracorporeal Life Support: The ELSO Red Book, Extracorporeal Life Support Organization. [5th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zavalichi, M.A., Nistor, I., Nedelcu, A.E., Zavalichi, S.D., Georgescu, C.M.A., St\u0103tescu, C., and Covic, A. (2020). Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review. BioMed Res. Int., 2020.","DOI":"10.1155\/2020\/6126534"},{"key":"ref_3","unstructured":"Extracorporeal Life Support Organization (2023). Extracorporeal Life Support Registry Report, International Summary, Extracorporeal Life Support Organization."},{"key":"ref_4","first-page":"290","article-title":"Predictors of mortality following extracorporeal membrane oxygenation support in an unselected, critically ill patient population","volume":"17","author":"Szilveszter","year":"2021","journal-title":"Adv. Interv. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ehjci\/ehaa946.1237","article-title":"Predictors of mortality in patients with VA-extracorporeal membrane oxygenation","volume":"41","author":"Kang","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.21037\/jtd-21-1770","article-title":"Predictors associated with mortality of extracorporeal life support therapy for acute heart failure: Single-center experience with 679 patients","volume":"14","author":"Sahli","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12265-021-10140-w","article-title":"Predictors of Mortality in Patients Treated with Veno-Arterial ECMO for Cardiogenic Shock Complicating Acute Myocardial Infarction: A Systematic Review and Meta\u2013Analysis","volume":"15","author":"Sohail","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Treml, B., Breitkopf, R., Bukumiri\u0107, Z., Bachler, M., Boesch, J., and Rajsic, S. (2022). ECMO Predictors of Mortality: A 10-Year Referral Centre Experience. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051224"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/jocs.14758","article-title":"Clinical predictors of in-hospital mortality in venoarterial extracorporeal membrane oxygenation","volume":"35","author":"Vigneshwar","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_10","first-page":"172","article-title":"A meta-analysis of complications and mortality of extracorporeal membrane oxygenation","volume":"15","author":"Zangrillo","year":"2013","journal-title":"Crit. Care Resusc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13613-022-01067-9","article-title":"Extracorporeal membrane oxygenation for cardiogenic shock: A meta-analysis of mortality and complications","volume":"12","author":"Rajsic","year":"2022","journal-title":"Ann. Intensive Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13613-016-0196-7","article-title":"Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation","volume":"6","author":"Aubron","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MAT.0000000000000525","article-title":"Therapeutic Interventions and Risk Factors of Bleeding During Extracorporeal Membrane Oxygenation","volume":"63","author":"Lotz","year":"2017","journal-title":"ASAIO J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MAT.0000000000001230","article-title":"Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review","volume":"67","author":"Olson","year":"2021","journal-title":"ASAIO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcrc.2019.09.013","article-title":"Hemorrhagic complications during extracorporeal membrane oxygenation\u2014The role of anticoagulation and platelets","volume":"54","author":"Droogh","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rajsic, S., Breitkopf, R., Jadzic, D., Popovic Krneta, M., Tauber, H., and Treml, B. (2022). Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175147"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0267","DOI":"10.1097\/CCE.0000000000000267","article-title":"Bleeding, Thromboembolism, and Clinical Outcomes in Venovenous Extracorporeal Membrane Oxygenation","volume":"2","author":"Stokes","year":"2020","journal-title":"Crit. Care Explor."},{"key":"ref_18","unstructured":"Lequier, G.A.L., Al-Ibrahim, O., Bembea, M., Brodie, D., Brogan, T., Buckvold, S., Chicoine, L., Conrad, S., Cooper, D., and Dalton, H. (2014). ELSO Anticoagulation Guideline, ELSO."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rajsic, S., Breitkopf, R., Bachler, M., and Treml, B. (2021). Diagnostic Modalities in Critical Care: Point-of-Care Approach. Diagnostics, 11.","DOI":"10.3390\/diagnostics11122202"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"154332","DOI":"10.1016\/j.jcrc.2023.154332","article-title":"aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis","volume":"77","author":"Rajsic","year":"2023","journal-title":"J. Crit. Care"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Rajsic, S., Breitkopf, R., Treml, B., Jadzic, D., Oberleitner, C., Oezpeker, U.C., Innerhofer, N., and Bukumiric, Z. (2023). Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12093224"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjh.17870","article-title":"Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: A multicentre observational study","volume":"196","author":"Arachchillage","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Altman","year":"2007","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MAT.0000000000001652","article-title":"2021 ELSO Adult and Pediatric Anticoagulation Guidelines","volume":"68","author":"McMichael","year":"2022","journal-title":"ASAIO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.21037\/jtd.2020.04.54","article-title":"Extracorporeal membrane oxygenation without systemic anticoagulation: A case-series in challenging conditions","volume":"12","author":"Fina","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PCC.0000000000003215","article-title":"Anticoagulation-Free Pediatric Extracorporeal Membrane Oxygenation: Single-Center Retrospective Study","volume":"24","author":"Rabinowitz","year":"2023","journal-title":"Pediatr. Crit. Care Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.jvca.2023.02.018","article-title":"Anticoagulation-free Extracorporeal Membrane Oxygenation in Severe Bronchial and Lung Trauma","volume":"37","author":"Yuan","year":"2023","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S336","DOI":"10.1016\/j.healun.2019.01.850","article-title":"Feasibility and Safety of Systemic Anticoagulation-Free Veno-Venous Extracorporeal Membrane Oxygenation in Adults Respiratory Failure Patients","volume":"38","author":"Kurihara","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rajsic, S., Breitkopf, R., Oezpeker, U.C., Bukumiri\u0107, Z., Dobesberger, M., and Treml, B. (2022). The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092314"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rajsic, S., Breitkopf, R., Rugg, C., Bukumiric, Z., Reitbauer, J., and Treml, B. (2023). Thrombotic Events Develop in 1 Out of 5 Patients Receiving ECMO Support: An 11-Year Referral Centre Experience. J. Clin. Med., 12.","DOI":"10.3390\/jcm12031082"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jtcvs.2021.10.077","article-title":"Long-term survival and quality of life after extracorporeal membrane oxygenation","volume":"166","author":"Rossong","year":"2023","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ehf2.12433","article-title":"Health-related quality of life after extracorporeal membrane oxygenation: A single centre\u2019s experience","volume":"6","author":"Karlsen","year":"2019","journal-title":"ESC Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13613-021-00975-6","article-title":"Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock","volume":"11","author":"Stadlbauer","year":"2021","journal-title":"Ann. Intensive Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jtcvs.2012.01.005","article-title":"Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: A case-control study","volume":"143","author":"Pieri","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/adc.2005.077446","article-title":"Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome","volume":"91","author":"Arkader","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/bja\/83.4.602","article-title":"Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations","volume":"83","author":"Aouifi","year":"1999","journal-title":"Br. J. Anaesth."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1097\/01.CCM.0000239116.01855.61","article-title":"Procalcitonin increase in early identification of critically ill patients at high risk of mortality","volume":"34","author":"Jensen","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_39","first-page":"305","article-title":"Systemic inflammatory response following acute myocardial infarction","volume":"12","author":"Fang","year":"2015","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_40","first-page":"205","article-title":"Procalcitonin in patients with acute myocardial infarction","volume":"114","author":"Remskar","year":"2002","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): A review of the pathophysiology","volume":"20","author":"Millar","year":"2016","journal-title":"Crit. Care"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4068\/cmj.2018.54.1.48","article-title":"Predictive Value of Procalcitonin for Infection and Survival in Adult Cardiogenic Shock Patients Treated with Extracorporeal Membrane Oxygenation","volume":"54","author":"Kim","year":"2018","journal-title":"Chonnam Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Koziol, K.J., Isath, A., Rao, S., Gregory, V., Ohira, S., Van Diepen, S., Lorusso, R., and Krittanawong, C. (2023). Extracorporeal Membrane Oxygenation (VA-ECMO) in Management of Cardiogenic Shock. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175576"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"ref_45","first-page":"482","article-title":"Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: The multicentre, randomised EURO SHOCK trial","volume":"19","author":"Banning","year":"2023","journal-title":"EuroIntervention J. EuroPCR Collab. Work. Group Interv. Cardiol. Eur. Soc. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal Life Support in Infarct-Related Cardiogenic Shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1053\/j.jvca.2021.12.027","article-title":"One-Year Survival for Adult Venoarterial Extracorporeal Membrane Oxygenation Patients Requiring Renal-Replacement Therapy","volume":"36","author":"Levin","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/aor.12695","article-title":"The Impact of Renal Failure and Renal Replacement Therapy on Outcome During Extracorporeal Membrane Oxygenation Therapy","volume":"40","author":"Antonucci","year":"2016","journal-title":"Artif. Organs"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/24\/3683\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:18Z","timestamp":1760132418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/24\/3683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,17]]},"references-count":48,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["diagnostics13243683"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13243683","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2023,12,17]]}}}